We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
+14.78%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$3.74B
AUM Growth
+$210M
Cap. Flow
-$188M
Cap. Flow %
-5.03%
Top 10 Hldgs %
16.39%
Holding
1,456
New
147
Increased
521
Reduced
429
Closed
232

Sector Composition

Rank Sector Weight
1 Technology 24.13%
2 Energy 12.45%
3 Healthcare 10.2%
4 Communication Services 6.83%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNTX icon
851
BioNTech
BNTX
$23.5B
$131K ﹤0.01%
1,240
+314
+34% +$31.6K
TGT icon
852
Target
TGT
$66.3B
$130K ﹤0.01%
916
+878
+2,311% +$107K
RCUS icon
853
Arcus Biosciences
RCUS
$3.33B
$130K ﹤0.01%
6,816
+1,729
+34% +$27.6K
IMRX icon
854
Immuneering
IMRX
$262M
$128K ﹤0.01%
17,416
+4,417
+34% +$29.4K
LEGN icon
855
Legend Biotech
LEGN
$3.65B
$127K ﹤0.01%
2,113
-1,305
-38% -$82.7K
PGEN icon
856
Precigen
PGEN
$1.94B
$126K ﹤0.01%
94,091
+23,859
+34% +$28K
ITOS
857
DELISTED
iTeos Therapeutics
ITOS
$125K ﹤0.01%
11,379
+2,885
+34% +$28.6K
MMM icon
858
3M
MMM
$91.8B
$124K ﹤0.01%
1,356
-81,087
-98% -$6.51M
CUBE icon
859
CubeSmart
CUBE
$9.61B
$123K ﹤0.01%
2,643
-368
-12% -$14.5K
WTTR icon
860
Select Water Solutions
WTTR
$2.22B
$122K ﹤0.01%
16,069
-562
-3% -$4.18K
LSCC icon
861
Lattice Semiconductor
LSCC
$16B
$122K ﹤0.01%
1,767
-33
-2% -$2.19K
BCYC
862
Bicycle Therapeutics
BCYC
$270M
$122K ﹤0.01%
6,727
+1,706
+34% +$28.2K
IMTX icon
863
Immatics
IMTX
$1.23B
$121K ﹤0.01%
11,501
+2,916
+34% +$26.8K
CVS icon
864
CVS Health
CVS
$135B
$121K ﹤0.01%
1,533
-4,460
-74% -$317K
ELVN icon
865
Enliven Therapeutics
ELVN
$3.78B
$121K ﹤0.01%
8,708
+2,208
+34% +$27K
LSTR icon
866
Landstar System
LSTR
$6.03B
$119K ﹤0.01%
616
+92
+18% +$16.3K
GMAB icon
867
Genmab
GMAB
$17.5B
$118K ﹤0.01%
3,691
+936
+34% +$29.4K
CELH icon
868
Celsius Holdings
CELH
$7.39B
$117K ﹤0.01%
2,155
+43
+2% +$2.29K
JPM icon
869
JPMorgan Chase
JPM
$917B
$117K ﹤0.01%
686
-51,204
-99% -$7.76M
ERAS icon
870
Erasca
ERAS
$6.15B
$116K ﹤0.01%
54,339
+13,779
+34% +$29.1K
ALLO icon
871
Allogene Therapeutics
ALLO
$625M
$116K ﹤0.01%
36,040
+9,139
+34% +$25.9K
SQM icon
872
Sociedad Química y Minera de Chile
SQM
$19.3B
$115K ﹤0.01%
1,904
-12
-0.6% -$635
FR icon
873
First Industrial Realty Trust
FR
$8.66B
$113K ﹤0.01%
2,141
-1,239
-37% -$57.7K
DLO icon
874
dLocal
DLO
$4.29B
$112K ﹤0.01%
6,340
+8
+0.1% +$143
LEG icon
875
Leggett & Platt
LEG
$1.4B
$111K ﹤0.01%
4,237
-323
-7% -$7.92K

Similar funds

Exchange Traded Concepts's Q4 2023 Portfolio in Review

As of Q4 2023, Exchange Traded Concepts held 1,456 positions worth $3.74B, up 5.9% from $3.53B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Exchange Traded Concepts withdrew a net $188M in Q4 2023, closing 232 positions and reducing 429 holdings. Its most notable exit was iShares 0-3 Month Treasury Bond ETF, an estimated $366M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Exchange Traded Concepts opened a new position in State Street Utilities Select Sector SPDR ETF worth $63M.

  • Exchange Traded Concepts's largest Q4 2023 buy was State Street Utilities Select Sector SPDR ETF: 1,990,668 shares worth $63M.
  • Exchange Traded Concepts added most to Vanguard Real Estate ETF in Q4 2023, an estimated $91.9M increase.
  • Exchange Traded Concepts's biggest Q4 2023 reduction was Vanguard Energy ETF, cutting an estimated $21.6M.
  • Exchange Traded Concepts fully exited iShares 0-3 Month Treasury Bond ETF in Q4 2023, selling an estimated $366M.
  • Exchange Traded Concepts's ten largest holdings make up 16% of its $3.74B portfolio in Q4 2023.
  • Exchange Traded Concepts opened 147 new positions and closed 232 in Q4 2023.
  • Exchange Traded Concepts's portfolio value rose 5.9% quarter-over-quarter to $3.74B.

Based on Exchange Traded Concepts's 13F filing for Q4 2023, filed 5 Jan 2024.